News from johnson & johnson A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Jun 20, 2022, 20:00 ET Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of the new J&J Satellite Center for Global Health Discovery (Satellite Center) ...

Jun 19, 2022, 00:30 ET Johnson's® and Karan Patel celebrate gentle moments on this Father's Day

Jun 16, 2022, 09:00 ET Los principales agentes de cambio locales que abordan las brechas de equidad en la salud en los Estados Unidos ganan el Reto de Innovación en Equidad Sanitaria de Johnson & Johnson

Jun 14, 2022, 08:00 ET Top Local Changemakers Addressing Health Equity Gaps Across the U.S. Named Johnson & Johnson Health Equity Innovation Challenge Awardees

After an extensive search for the top changemakers in six key U.S. cities, Johnson & Johnson today announced the 14 awardees of its Health Equity...

Jun 08, 2022, 08:00 ET Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments

Johnson & Johnson (NYSE: JNJ) today published its 2021 Health for Humanity Report, which shares progress against its purpose-driven Health for...

May 12, 2022, 16:30 ET Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference at the Terranea Resort, Rancho Palos...

May 11, 2022, 06:30 ET Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

Johnson & Johnson (the "Company") (NYSE: JNJ) today announced the appointment of Thibaut Mongon as Chief Executive Officer Designate and Paul Ruh as...

May 02, 2022, 16:30 ET Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein 38th Annual Strategic Decisions Conference on Wednesday, June 1st, at the New York...

Apr 25, 2022, 07:30 ET Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)

The new Center is focused on outpacing the rising threat of antimicrobial resistance (AMR) and builds on Johnson & Johnson's longstanding commitment...

Apr 20, 2022, 16:30 ET Johnson & Johnson to Participate in the UBS Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24th. Mathai Mammen, Executive Vice President, ...

Apr 19, 2022, 06:25 ET Johnson & Johnson Reports Q1 2022 Results

Total sales growth of 5.0% to $23.4 Billion with operational growth of 7.7%* and adjusted operational growth of 7.9%* Earnings per share of $1.93...

Apr 19, 2022, 06:20 ET Johnson & Johnson Announces Dividend Increase of 6.6%

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 6.6% increase in the quarterly dividend, from $1.06 per...

Apr 07, 2022, 16:30 ET Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference

NEW BRUNSWICK, N.J., April 7, 2022 Johnson & Johnson (NYSE: JNJ) will participate in the BofA Securities 2022 Healthcare Conference at the Encore...

Mar 15, 2022, 08:20 ET Johnson & Johnson to Host Investor Conference Call on First-Quarter Results

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, April 19th to review first-quarter...

Feb 15, 2022, 16:30 ET Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors

Johnson & Johnson (NYSE: JNJ) announced today that Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, has been appointed to its...

Feb 09, 2022, 16:28 ET Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 43rd Annual Institutional Investors Conference on Tuesday, March 8th. Joseph J....

Feb 07, 2022, 16:51 ET Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 42nd Annual Health Care Virtual Conference on Monday, March 7th. Mathai Mammen, Executive ...

Jan 27, 2022, 17:28 ET Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in Citi's 2022 Virtual Healthcare Conference on Wednesday, February 23rd, Ashley McEvoy, Executive...

Jan 25, 2022, 06:25 ET Johnson & Johnson Reports Q4 and Full-Year 2021 Results

Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021. "Our 2021 performance reflects continued strength across ...

Jan 06, 2022, 16:10 ET Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States

Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the...

Jan 04, 2022, 08:00 ET Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2022 of $1.06 per...

Dec 30, 2021, 06:30 ET Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant

Johnson & Johnson (NYSE: JNJ) (the Company) today announced new preliminary results from the South African Phase 3b Sisonke study which showed that a ...

Dec 15, 2021, 08:32 ET Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...

Dec 10, 2021, 13:39 ET Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, January 25th to review fourth-quarter ...